Search Cosmetics & Toiletries: Page 9

182 Results

Type: Article

Section: Regulations > Claims/Labeling

Silicone Safety and the Cosmetic Industry

The use of silicones in personal care products continues to expand because of the unique performance attributes they provide and their well-established record of safety. As a result, progressively larger volumes of silicones are being released to the environment, and interest in their life cycle has increased. The present article summarizes relevant fundamental chemical and physical properties of silicones and how these relate to material performance, safety and environmental fate.

'May Contain' Ingredient Disclosures

The US Code of Federal Regulations lists1 the rules for displaying ingredients, and besides outlining the content that must be included and its order of appearance, the regulation describes use of the “may contain” clause, which while legally only applies to pigments, has been abused and is thus the main topic of this column.

EU Regulatory Update: Cosmetic Ingredients Under EU Scrutiny

In the EU, numerous mandates for new scientific opinions have been posted in 2011, with a specification of the assessment criteria and goals. The application areas mostly focus on the new and ongoing ingredient assessments of hair dyes, preservatives and UV filters.

Industry Debate: US FDA vs. Sunscreens

During last month’s NYSCC Suppliers' Day, several attendees expressed frustration regarding the delay of the US Food and Drug Administration’s Final Sunscreen Monograph. Cosmetics & Toiletries asked its LinkedIn members to comment. Here’s what the market had to say.

Naturals: The New Cosmetic Religion

There is a connection between religion and cosmetics, and that connection is naturals. Naturals are the new (cosmetic) religion. This column's provocative title tries to link the evidence for the existence of God to the evidence for the claimed benefits of naturals.

Comparatively Speaking: Cosmetic Labeling in the United States

In this excerpt, Tony O'Lenick looks to Perry Romanowski to explain how to list ingredients on a cosmetic product label in the United States, for the benefit of novice formulators.

Is Cosmetic Science Really "Bad"? Part V: Who do you think you are fooling?

In previous installments of this series, the author applied Michael Shermer's Baloney Detection Kit, which includes ten questions to ask to validate a science, to cosmetic science. Having previously applied the first eight questions, the author addresses the final two in this installment.

Certifying Hair Product Claims

Claims for hair products generally are not associated with clear cut outcomes. Therefore, consumers have no standard by which to compare product efficacy. In relation, the North American Hair Research Society (NAHRS) has proposed standards for hair product claims, outlined here, which relate to characteristics including frizz, color fastness and curl retention, among others.

Function vs. Size: Patenting Nano-scale Cosmetic Invention

Nanometer-scale components are increasingly appearing in cosmetic formulations and a corresponding increase in related patents has occurred. To assist inventors and formulators in protecting nano-scale inventions, this article describes approaches to claimed inventions and illustrates key variables that formulators can monitor and record to give a patent the best chance of later being found valid and infringed.

Is Cosmetic Science Really "Bad"? Part IV: How Scientific is Cosmetic Science?

Six questions from Michael Shermer’s Baloney Detection Kit have been discussed in this series. The results were not flattering for cosmetic science (read: cosmetic scientists) but cosmetic science did not score badly on all points. Questions seven and eight, described here, discriminate true science from borderland science and non-science or nonsense.

EU Regulatory Update: CLP Deadlines and Consequences

The European Union’s adaptation of the Globally Harmonized System (GHS) is Regulation (EC) No. 1272/2008 on the classification, labeling and packaging (CLP) of substances and mixtures, which entered into force on Jan. 20, 2009.

Translating Data into Claims and Interpreting Regulations: Science vs. Marketing

Substantial evidence, which the FDA requires to support claims for drugs, is applicable to personal care, especially considering the pharmaceutical direction products have taken. The present article considers whether the industry is benefiting from marketing without assuming the responsibility for potential effects. In addition, it considers the limitations of in vitro and in vivo test models.

Recent ATPs and the 8th Amendment

Why does the Cosmetic Directive need the 8th Amendment? Some feel it is necessary since the directive has been changed 55 times, including seven amendments and 48 Adaptations to Technical Progress (ATPs). While the industry waits to see what this new amendment will bring, more ATPs have been published, as are described here. Science moves on contrary to political wishes.

Is Cosmetics Science Really "Bad"? Part III: Evidence to Support Claims in the Real World

This is the third column of a series that applies Michael Shermer's "Baloney Detection Kit" to cosmetic science. This column tackles the fourth, fifth and sixth of ten core questions included in the "kit": those relating to claims substantiation.

Simple Pleasures

I hope this issue of C&T magazine not only finds you in good health and brings you cheer, but also stokes your creative fire. While it’s not quite that cup of hot apple cider, this issue warrants pouring yourself one with which to sit back, relax and simply enjoy a good read.

Net Contents of a Cosmetic: The ‘E’ Mark and Units of Measure

Recently, some European Union member states have expressed concern over the misuse of the Estimated Symbol (℮), often referred to as the “e” mark, on product labels. In addition, some regulators have argued that the International System of Units, known as the metric system, should be used on all product labels to indicate the net contents of a finished product. Both of these concerns have fueled the present column in which the author debates how product labels should indicate the net contents of a cosmetic product. In closing, he comments on the jurisdiction of the CPSC in the United States.

In the Land of the Blind: Applying a Single-blind Study to Finished Products

Following positive feedback from a previous column on the placebo effect, Wiechers readdresses clinical study design in relation to cosmetic claim substantiation—this time discussing when to perform double-blind studies and when to perform single-blind studies.

Labeling Claims

Little is more confusing to marketers and cosmetic formulators than product claims regulations. Questions regarding the rules commonly arise.

Page 9 of 11